267 related articles for article (PubMed ID: 23302008)
1. Controlling anisotropic drug diffusion in lipid-Fe3O4 nanoparticle hybrid mesophases by magnetic alignment.
Vallooran JJ; Negrini R; Mezzenga R
Langmuir; 2013 Jan; 29(4):999-1004. PubMed ID: 23302008
[TBL] [Abstract][Full Text] [Related]
2. Twofold light and magnetic responsive behavior in nanoparticle-lyotropic liquid crystal systems.
Vallooran JJ; Handschin S; Bolisetty S; Mezzenga R
Langmuir; 2012 Apr; 28(13):5589-95. PubMed ID: 22414249
[TBL] [Abstract][Full Text] [Related]
3. Oil and drug control the release rate from lyotropic liquid crystals.
Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
[TBL] [Abstract][Full Text] [Related]
4. A novel lyotropic liquid crystal formed by triphilic star-polyphiles: hydrophilic/oleophilic/fluorophilic rods arranged in a 12.6.4. tiling.
de Campo L; Varslot T; Moghaddam MJ; Kirkensgaard JJ; Mortensen K; Hyde ST
Phys Chem Chem Phys; 2011 Feb; 13(8):3139-52. PubMed ID: 21103506
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of hydrophobic guest molecules in the monoolein discontinuous QL cubic mesophase and its soft nanoparticles.
Efrat R; Kesselman E; Aserin A; Garti N; Danino D
Langmuir; 2009 Feb; 25(3):1316-26. PubMed ID: 18781793
[TBL] [Abstract][Full Text] [Related]
7. Solvation Dynamics in Different Phases of the Lyotropic Liquid Crystalline System.
Roy B; Satpathi S; Gavvala K; Koninti RK; Hazra P
J Phys Chem B; 2015 Sep; 119(35):11721-31. PubMed ID: 26258397
[TBL] [Abstract][Full Text] [Related]
8. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
Zabara A; Mezzenga R
J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
[TBL] [Abstract][Full Text] [Related]
9. Tuning in-meso-crystallized lysozyme polymorphism by lyotropic liquid crystal symmetry.
Zabara A; Amar-Yuli I; Mezzenga R
Langmuir; 2011 May; 27(10):6418-25. PubMed ID: 21506575
[TBL] [Abstract][Full Text] [Related]
10. On the thermotropic and magnetotropic phase behavior of lipid liquid crystals containing magnetic nanoparticles.
Mendozza M; Montis C; Caselli L; Wolf M; Baglioni P; Berti D
Nanoscale; 2018 Feb; 10(7):3480-3488. PubMed ID: 29404545
[TBL] [Abstract][Full Text] [Related]
11. Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C.
Bitan-Cherbakovsky L; Yuli-Amar I; Aserin A; Garti N
Langmuir; 2010 Mar; 26(5):3648-53. PubMed ID: 20175578
[TBL] [Abstract][Full Text] [Related]
12. Lyotropic Cubic Phases for Drug Delivery: Diffusion and Sustained Release from the Mesophase Evaluated by Electrochemical Methods.
Nazaruk E; Miszta P; Filipek S; Górecka E; Landau EM; Bilewicz R
Langmuir; 2015 Nov; 31(46):12753-61. PubMed ID: 26513537
[TBL] [Abstract][Full Text] [Related]
13. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
14. Anomalous phase sequences in lyotropic liquid crystals.
Lee WB; Mezzenga R; Fredrickson GH
Phys Rev Lett; 2007 Nov; 99(18):187801. PubMed ID: 17995439
[TBL] [Abstract][Full Text] [Related]
15. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A.
Libster D; Ishai PB; Aserin A; Shoham G; Garti N
Int J Pharm; 2009 Feb; 367(1-2):115-26. PubMed ID: 18977286
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate.
Báez-Santos YM; Otte A; Mun EA; Soh BK; Song CG; Lee YN; Park K
Int J Pharm; 2016 Nov; 514(1):314-321. PubMed ID: 27863678
[TBL] [Abstract][Full Text] [Related]
19. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
[TBL] [Abstract][Full Text] [Related]
20. Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.
Rajesh S; Zhai J; Drummond CJ; Tran N
J Colloid Interface Sci; 2021 May; 589():85-95. PubMed ID: 33450463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
